Olema Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:OLMA) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -27.02 M-26.28 M-43.98 M-29.88 M-34.53 M -134.67 M Cash from investing activities 45.92 M-114.42 M-45.08 M34.23 M17.27 M -108 M Cash from financing activities 92 K244.3 M222 K-2.52 M41 K 242.04 M Free cash flow -27.02 M-26.28 M-43.98 M-29.88 M-34.53 M -134.67 M

Notizie

Olema: perdite in aumento prima dei dati chiave

Olema earnings on deck: Biotech faces widening loss ahead of key data

Olema Pharmaceuticals, Inc. (OLMA) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Olema Pharmaceuticals, Inc. (OLMA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Stifel avvia la copertura di Olema Pharmaceuticals con rating Buy e target di $48

Stifel initiates Olema Pharmaceuticals stock with Buy rating, $48 target

Il titolo di Olema Pharmaceuticals scende dopo l’annuncio delle dimissioni del CFO

Olema Pharmaceuticals stock falls after CFO announces departure

Olema Pharmaceuticals CFO Shane Kovacs departs, CEO assumes interim finance role

Il CFO di Olema Oncology Shane Kovacs lascerà dopo sei anni di servizio

Olema Oncology CFO Shane Kovacs to depart after six-year tenure

Harmon Cyrus, direttore di Olema, vende azioni per $268.800